Ignite Creation Date:
2024-05-05 @ 10:46 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01184261
Status:
COMPLETED
Last Update Posted:
2014-03-26
First Post:
2010-08-17
Brief Title:
Integrated Behavioral Intervention for Cigarette Smoking and Binge Drinking in Young Adults
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Integrated Intervention for Cigarette Smoking and Binge Drinking for Young Adults
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Nicotine patches and behavioral therapy may help reduce cigarette smoking and binge drinking in young adults PURPOSE This randomized clinical trial studies nicotine patches with or without behavioral therapy in reducing cigarette smoking and binge drinking in young adults
Detailed Description:
OBJECTIVES I To evaluate the efficacy of Integrated Intervention that targets both cigarette smoking and binge drinking on the cigarette smoking behavior of young adult smokers at 6-month follow-up II To evaluate the efficacy of Integrated Intervention that targets both cigarette smoking and binge drinking on binge drinking behavior of young adult smokers III Examine the effect of Integrated Intervention on several possible mediators of change corresponding to mechanisms that have been proposed to account for the relationship between cigarette smoking and alcohol use These mediators include cravings to smoke perceived similarity to the typical smoker and self-efficacy for smoking abstinence OUTLINE Patients are randomized to 1 of 2 treatment armsAll patients receive nicotine patch therapy in weeks 4-11 ARM I Patients attend behavioral sessions for smoking and binge drinking cessation over 30 minutes once weekly in weeks 1-6 ARM II Patients attend behavioral sessions for smoking cessation over 30 minutes once weekly in weeks 1-6After completion of study treatment patients are followed up at weeks 12 16 20 and 24
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2010-01881 | None | None | None |